Skip to main content
logo
Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
1.910
-0.030 (-1.55%)
At close: Jul 31, 2026, 4:00 PM EDT
1.930
+0.020 (1.05%)
Pre-market: Aug 3, 2026, 5:30 AM EDT

Compass Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
344958200199635320
Market Cap Growth
-18.44%379.19%0.34%-68.65%98.76%-
Enterprise Value
159.07758.5279.7548.43451.63179.16
Last Close Price
1.915.371.451.565.033.17

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--235.11---
PB Ratio
1.844.871.601.343.502.28
P/TBV Ratio
1.744.301.591.332.911.42

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
--93.82---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.050.040.050.000.010.02
Net Debt / Equity Ratio
-0.99-1.01-0.96-1.01-1.01-1.00
Net Debt / EBITDA Ratio
2.471.371.063.044.491.73
Net Debt / FCF Ratio
3.474.052.683.715.356.62
Asset Turnover
-00.01000
Quick Ratio
18.9414.9614.2819.5411.5413.59
Current Ratio
19.0415.0214.9619.7312.0513.84
Return on Equity (ROE)
-35.58%-41.29%-36.07%-25.74%-24.38%-91.30%
Return on Assets (ROA)
-35.40%-80.93%-76.76%-28.25%-23.57%-79.63%
Return on Invested Capital (ROIC)
--10190.84%-7722.50%---9077.83%
Return on Capital Employed (ROCE)
-37.54%-86.42%-81.32%-30.29%-25.51%-88.55%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-23.18%-14.78%-8.15%-20.76%-67.31%-104.28%
Total Shareholder Return
-23.18%-14.78%-8.15%-20.76%-67.31%-104.28%
SEC Filings: 10-K · 10-Q